MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 527022 | Name: Cl-APB

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Cl-APB is a dopamine D1 receptor agonist.

Chemical Structure

Cl-APB
Cl-APB
CAS#80751-65-1

Theoretical Analysis

MedKoo Cat#: 527022

Name: Cl-APB

CAS#: 80751-65-1

Chemical Formula: C19H20ClNO2

Exact Mass: 329.1183

Molecular Weight: 329.82

Elemental Analysis: C, 69.19; H, 6.11; Cl, 10.75; N, 4.25; O, 9.70

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Cl-APB
IUPAC/Chemical Name
9-Chloro-5-phenyl-3-prop-2-enyl-1,2,4,5-tetrahydro-3-benzazepine-7,8-diol
InChi Key
HJWHHQIVUHOBQN-UHFFFAOYSA-N
InChi Code
InChI=1S/C19H20ClNO2/c1-2-9-21-10-8-14-15(11-17(22)19(23)18(14)20)16(12-21)13-6-4-3-5-7-13/h2-7,11,16,22-23H,1,8-10,12H2
SMILES Code
OC1=C(O)C(Cl)=C2CCN(CC=C)CC(C3=CC=CC=C3)C2=C1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 329.82 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Lazenka MF, Freitas KC, Henck S, Negus SS. Relief of Pain-Depressed Behavior in Rats by Activation of D1-Like Dopamine Receptors. J Pharmacol Exp Ther. 2017 Jul;362(1):14-23. doi: 10.1124/jpet.117.240796. Epub 2017 Apr 14. PubMed PMID: 28411257; PubMed Central PMCID: PMC5454591. 2: Ouyang J, Carcea I, Schiavo JK, Jones KT, Rabinowitsch A, Kolaric R, Cabeza de Vaca S, Froemke RC, Carr KD. Food restriction induces synaptic incorporation of calcium-permeable AMPA receptors in nucleus accumbens. Eur J Neurosci. 2017 Mar;45(6):826-836. doi: 10.1111/ejn.13528. Epub 2017 Feb 15. PubMed PMID: 28112453; PubMed Central PMCID: PMC5359088. 3: Kohnomi S, Ebihara K, Kobayashi M. Suppressive regulation of lateral inhibition between medium spiny neurons via dopamine D(1) receptors in the rat nucleus accumbens shell. Neurosci Lett. 2017 Jan 1;636:58-63. doi: 10.1016/j.neulet.2016.10.049. Epub 2016 Oct 26. PubMed PMID: 27793700. 4: Rapanelli M, Frick LR, Horn KD, Schwarcz RC, Pogorelov V, Nairn AC, Pittenger C. The Histamine H3 Receptor Differentially Modulates Mitogen-activated Protein Kinase (MAPK) and Akt Signaling in Striatonigral and Striatopallidal Neurons. J Biol Chem. 2016 Sep 30;291(40):21042-21052. Epub 2016 Aug 10. PubMed PMID: 27510032; PubMed Central PMCID: PMC5076514. 5: Spoelder M, Baars AM, Rotte MD, Vanderschuren LJ, Lesscher HM. Dopamine receptor agonists modulate voluntary alcohol intake independently of individual levels of alcohol intake in rats. Psychopharmacology (Berl). 2016 Jul;233(14):2715-25. doi: 10.1007/s00213-016-4330-x. Epub 2016 May 28. PubMed PMID: 27236784; PubMed Central PMCID: PMC4917576. 6: Tratnjek L, Glavan G, Višnjar T, Živin M. Upregulation and axonal transport of synaptotagmin-IV in the direct-pathway medium spiny neurons in hemi-parkinsonian rats induced by dopamine D1 receptor stimulation. Eur J Neurosci. 2016 Apr;43(7):885-98. doi: 10.1111/ejn.13161. Epub 2016 Feb 23. PubMed PMID: 26750488. 7: Kotani M, Kiyoshi A, Murai T, Nakako T, Matsumoto K, Matsumoto A, Ikejiri M, Ogi Y, Ikeda K. The dopamine D1 receptor agonist SKF-82958 effectively increases eye blinking count in common marmosets. Behav Brain Res. 2016 Mar 1;300:25-30. doi: 10.1016/j.bbr.2015.11.028. Epub 2015 Dec 7. PubMed PMID: 26675887. 8: Wilson JM, Ogden AM, Loomis S, Gilmour G, Baucum AJ 2nd, Belecky-Adams TL, Merchant KM. Phosphodiesterase 10A inhibitor, MP-10 (PF-2545920), produces greater induction of c-Fos in dopamine D2 neurons than in D1 neurons in the neostriatum. Neuropharmacology. 2015 Dec;99:379-86. doi: 10.1016/j.neuropharm.2015.08.008. Epub 2015 Aug 7. PubMed PMID: 26256420. 9: Hryhorczuk C, Florea M, Rodaros D, Poirier I, Daneault C, Des Rosiers C, Arvanitogiannis A, Alquier T, Fulton S. Dampened Mesolimbic Dopamine Function and Signaling by Saturated but not Monounsaturated Dietary Lipids. Neuropsychopharmacology. 2016 Feb;41(3):811-21. doi: 10.1038/npp.2015.207. Epub 2015 Jul 14. PubMed PMID: 26171719; PubMed Central PMCID: PMC4707827. 10: Mosher LJ, Frau R, Pardu A, Pes R, Devoto P, Bortolato M. Selective activation of D1 dopamine receptors impairs sensorimotor gating in Long-Evans rats. Br J Pharmacol. 2016 Jul;173(13):2122-34. doi: 10.1111/bph.13232. Epub 2015 Jul 30. PubMed PMID: 26101934; PubMed Central PMCID: PMC4908197. 11: Sørensen G, Reddy IA, Weikop P, Graham DL, Stanwood GD, Wortwein G, Galli A, Fink-Jensen A. The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice. Physiol Behav. 2015 Oct 1;149:262-8. doi: 10.1016/j.physbeh.2015.06.013. Epub 2015 Jun 11. PubMed PMID: 26072178; PubMed Central PMCID: PMC4668599. 12: Barroso-Chinea P, Thiolat ML, Bido S, Martinez A, Doudnikoff E, Baufreton J, Bourdenx M, Bloch B, Bezard E, Martin-Negrier ML. D1 dopamine receptor stimulation impairs striatal proteasome activity in Parkinsonism through 26S proteasome disassembly. Neurobiol Dis. 2015 Jun;78:77-87. doi: 10.1016/j.nbd.2015.02.024. Epub 2015 Mar 10. PubMed PMID: 25766677. 13: Espinoza S, Ghisi V, Emanuele M, Leo D, Sukhanov I, Sotnikova TD, Chieregatti E, Gainetdinov RR. Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1. Neuropharmacology. 2015 Jun;93:308-13. doi: 10.1016/j.neuropharm.2015.02.010. Epub 2015 Feb 24. PubMed PMID: 25721394. 14: Chastain LG, Qu H, Bourke CH, Iuvone PM, Dobner PR, Nemeroff CB, Kinkead B. Striatal dopamine receptor plasticity in neurotensin deficient mice. Behav Brain Res. 2015 Mar 1;280:160-71. doi: 10.1016/j.bbr.2014.11.014. Epub 2014 Nov 15. PubMed PMID: 25449842; PubMed Central PMCID: PMC4496790. 15: Devoto P, Fattore L, Antinori S, Saba P, Frau R, Fratta W, Gessa GL. Elevated dopamine in the medial prefrontal cortex suppresses cocaine seeking via D1 receptor overstimulation. Addict Biol. 2016 Jan;21(1):61-71. doi: 10.1111/adb.12178. Epub 2014 Aug 19. PubMed PMID: 25135633. 16: Fish EW, DiBerto JF, Krouse MC, Robinson JE, Malanga CJ. Different contributions of dopamine D1 and D2 receptor activity to alcohol potentiation of brain stimulation reward in C57BL/6J and DBA/2J mice. J Pharmacol Exp Ther. 2014 Aug;350(2):322-9. doi: 10.1124/jpet.114.216135. Epub 2014 Jun 10. PubMed PMID: 24917543; PubMed Central PMCID: PMC4109490. 17: Wass C, Pizzo A, Sauce B, Kawasumi Y, Sturzoiu T, Ree F, Otto T, Matzel LD. Dopamine D1 sensitivity in the prefrontal cortex predicts general cognitive abilities and is modulated by working memory training. Learn Mem. 2013 Oct 15;20(11):617-27. doi: 10.1101/lm.031971.113. PubMed PMID: 24129098; PubMed Central PMCID: PMC3799419. 18: Der-Ghazarian T, Widarma CB, Gutierrez A, Amodeo LR, Valentine JM, Humphrey DE, Gonzalez AE, Crawford CA, McDougall SA. Behavioral effects of dopamine receptor inactivation in the caudate-putamen of preweanling rats: role of the D2 receptor. Psychopharmacology (Berl). 2014 Feb;231(4):651-62. doi: 10.1007/s00213-013-3280-9. Epub 2013 Sep 22. PubMed PMID: 24057816; PubMed Central PMCID: PMC3946740. 19: Soll LG, Grady SR, Salminen O, Marks MJ, Tapper AR. A role for α4(non-α6)* nicotinic acetylcholine receptors in motor behavior. Neuropharmacology. 2013 Oct;73:19-30. doi: 10.1016/j.neuropharm.2013.05.001. Epub 2013 May 17. PubMed PMID: 23688922; PubMed Central PMCID: PMC3784255. 20: Moreno-Smith M, Lee SJ, Lu C, Nagaraja AS, He G, Rupaimoole R, Han HD, Jennings NB, Roh JW, Nishimura M, Kang Y, Allen JK, Armaiz GN, Matsuo K, Shahzad MM, Bottsford-Miller J, Langley RR, Cole SW, Lutgendorf SK, Siddik ZH, Sood AK. Biologic effects of dopamine on tumor vasculature in ovarian carcinoma. Neoplasia. 2013 May;15(5):502-10. PubMed PMID: 23633922; PubMed Central PMCID: PMC3638353.